Robotic Surgery Vision Systems Patents: Who Leads, Trends 2026
- 81.5% concentration. The top five assignees combine for 2,914 of the 3,575 records in scope — a field with very little room left for a new entrant to build a broad claim position.
- Filing growth is down 35%. From 2021 (223 records) to 2024 (145 records, the last complete year), filings fell 35%, though 2025-2026 figures are still filling in under publication lag.
- Optics is a minority claim, not the core one. G02B optical elements appear in only 7.7% of records, while A61B diagnosis-and-surgery claims cover 90.9% — most vision-system IP is filed as part of a surgical device, not a standalone optics patent.
Filing growth compares 2021 (223 records) with 2024 (145) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 3,575 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
This dataset tracks 3,575 patent records published between 2015 and mid-2026 that combine surgical vision hardware — stereoscopic endoscopes, endoscope cameras, surgical vision systems — with specific functional claims: depth perception, image latency, fluorescence mode, lens fogging, camera control or display ergonomics. It is a narrower cut than surgical robotics broadly; a record has to claim both the imaging apparatus and one of these functional problems to be in scope.
The picture that emerges is one of deep concentration around a handful of platform holders, with the underlying optics and image-processing classes appearing as secondary claims layered onto a dominant surgical-device filing strategy rather than as a separately contested field.
Filing trends and technology composition
Two views of the same 3,575 records: how filing activity has moved year over year, and which IPC subclasses carry the claims.
Filing trend, 2017-2026
Filings peaked in 2018 at 353 records. Volume held above 220 a year through 2021 before declining; 2021 to 2024 (the last complete year) fell 35%, from 223 to 145 records. The 2025 and 2026 figures shown are understated because publication typically lags filing by around 18 months.
Technology composition by IPC subclass
A61B (diagnosis and surgery) appears in 90.9% of the 3,575 records, confirming that vision-system claims are filed predominantly as part of surgical devices. B25J (manipulators and robots) at 15.6% and H04N (pictorial communication) at 11.2% are the next largest classes; G02B (optics), G16H (healthcare informatics), G06T (image processing), G06F (digital data processing) and A61M (body-fluid devices) each sit under 8%, since a record can carry several classes these shares sum to more than 100%.
Shares are the percentage of the 3,575 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Robotic Surgery Vision Systems with Eureka
This page is one run against one query. Ask Eureka your own question about robotic surgery vision systems and every answer comes back with the patent numbers behind it.
Try EurekaKey cited patents
Stereoscopic-endoscope display control apparatus and stereoscopic endoscope system
A stereoscopic endoscope with left and right image pickup units captures parallactic images through laterally arranged objective lenses and CCDs, with variable focal distance via moving focusing lenses. A display control unit masks image pickup areas visible to only one of the two units, based on object-distance information, so the left and right displayed images correspond correctly.Filed by Olympus Corporation, published 2006-06-15 — an early and specific articulation of the depth-perception masking problem this dataset centres on.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US9095362B2 | Method for passively decoupling torque applied by a remote actuator into an independently rotating member | 2,134 |
| 2 | US7066879B2 | Insertable device and system for minimal access procedure | 1,758 |
| 3 | US8108072B2 | Methods and systems for robotic instrument tool tracking with adaptive fusion of kinematics information and i… | 1,743 |
| 4 | US8991678B2 | Surgical instrument with stowing knife blade | 1,682 |
| 5 | US20060178556A1 | Articulate and swapable endoscope for a surgical robot | 1,636 |
| 6 | US20190201136A1 | Method of HUB communication | 1,634 |
| 7 | US8551076B2 | Retrograde instrument | 1,616 |
| 8 | US8640788B2 | Motor interface for parallel drive shafts within an independently rotating member | 1,612 |
| 9 | US9216062B2 | Seals and sealing methods for a surgical instrument having an articulated end effector actuated by a drive sh… | 1,585 |
| 10 | US9226750B2 | Methods and systems for detecting clamping or firing failure | 1,549 |
Citation counts inside this corpus are a signal of influence within the searched set, not a measure of current relevance — older foundational filings accumulate citations simply by being available longer.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the data means for strategy
Three findings that shape where a new filing or a design-around effort should focus.
The field is effectively closed at the top
Five assignees account for 2,914 of the 3,575 records in scope. That level of concentration means broad claims on core stereoscopic-imaging and depth-perception mechanics are largely spoken for; new entrants are more likely to find room in narrower functional claims than in foundational apparatus claims.
Volume has cooled from its 2018 peak
Filings peaked at 353 in 2018 and have declined since, falling 35% from 223 records in 2021 to 145 in 2024, the most recent complete year. This does not necessarily mean the technology is exhausted — it may reflect consolidation of filing strategy among the leaders rather than declining interest.
Vision claims ride on device claims
A61B covers 90.9% of records while the purely optical class G02B covers only 7.7%. Most patent value here sits in how imaging integrates with a surgical device or workflow, not in the optical components themselves — a design-around strategy focused only on lens or sensor hardware may miss where the real claim scope sits.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to robotic surgery vision systems, with the prior art for and against each one.
Assignees and where the gaps sit
The ranked leaders hold the great majority of filings, but recent-year momentum shows even the top names slowing, which is where openings tend to appear.
One assignee dominates the ranking
The top-ranked assignee holds 2,497 of the 3,575 records in scope, an order of magnitude ahead of the fifth-place holder at 56. This is not a fragmented field with many equal competitors — it is one platform holder's filing programme plus a long tail.
Even leading filers are pulling back
Recent-year momentum shows sharp year-over-year declines across the top names, including one major holder down 92% YoY to 4 filings in the latest year and others down to zero. Read cautiously given the 18-month publication lag, but the direction is consistent across multiple leaders.
Co-assignment is limited and concentrated
Only 10 co-assignee pairs appear in the dataset, and the strongest pairs cluster around a small group of related corporate entities. This is a field where most filings are single-assignee, not joint ventures or shared research programmes.
| Assignee | Recent year | YoY |
|---|---|---|
| Smith & Nephew Inc | 5 | -17% |
| Smith & Nephew Asia Pacific Pte Ltd | 5 | -17% |
| Intuitive Surgical Operations Inc | 4 | -92% |
| Olympus Corporation | 0 | — |
| Cilag GmbH International | 0 | -100% |
| Intuitive Surgical Inc | 0 | — |
| Auris Health Inc | 0 | — |
| Sony Group Corporation | 0 | -100% |
Where to take this analysis
The trends above point to specific next questions depending on whether the goal is freedom-to-operate, portfolio strategy, or spotting an entry point.
Check freedom-to-operate against the leader's portfolio
With one assignee holding 2,497 of 3,575 records, any new filing in core stereoscopic or depth-perception mechanics needs a specific clearance check against that portfolio before drafting claims.
Run a freedom-to-operate check in EurekaMap the under-claimed functional branches
Lens fogging, display ergonomics and image-latency compensation show thinner claim density than the core A61B classes — worth a focused search before assuming the space is closed.
Explore white space in EurekaWatch momentum, not just volume
Several leading assignees show sharp year-over-year declines in the latest year; tracking whether this continues past the publication-lag window matters more than the raw filing count.
Track assignee momentum in EurekaCommon questions about this landscape
One assignee holds 2,497 of the 3,575 records in scope, far ahead of the fifth-ranked holder at 56 records. The top five assignees combined account for 81.5% of all records, and the top ten for 87.4%. This means the field is dominated by a small number of platform holders rather than being evenly spread across many competitors, which matters for anyone assessing freedom-to-operate before filing.
Filings peaked in 2018 at 353 records and have declined since; from 2021 to 2024, the last year that can be treated as complete, filings fell 35%, from 223 to 145 records. Figures for 2025 and 2026 look lower still, but that is expected because publication typically lags filing by around 18 months, so those years are not yet fully reported. The honest read is a field cooling from its 2018 peak, not one that has stopped moving.
The dominant class is A61B, diagnosis and surgery, appearing in 90.9% of the 3,575 records, which shows that most vision-system claims are written as part of a surgical device rather than as standalone optics. B25J, manipulators and robots, appears in 15.6% of records, and H04N, pictorial communication, in 11.2%. Purely optical claims under G02B appear in only 7.7% of records, so a search focused narrowly on lens or camera hardware will miss the majority of relevant filings.
Functional branches such as lens fogging mitigation under fluorescence mode, display ergonomics for stereoscopic viewing, and image latency compensation in camera control loops show comparatively thin claim density relative to the core A61B and B25J classes. Healthcare informatics integration with vision hardware, at 5.9% of records, is also relatively underdeveloped given how central data integration is becoming to surgical platforms. These are areas where a first mover could still stake out a specific, narrower claim rather than contesting the crowded core apparatus claims.
The most-cited record in this dataset, US9095362B2, covers a method for passively decoupling torque applied by a remote actuator into an independently rotating member, a mechanical linkage concept foundational to robotic instrument control rather than the vision system itself. Highly-cited patents in a searched corpus tend to be older filings that have simply had more time to accumulate citations, so a high count is a signal of historical influence, not necessarily of current commercial relevance. Anyone relying on citation rank for strategy should cross-check the underlying claim scope and filing date directly rather than treating the ranking as a measure of importance today.
Research Robotic Surgery Vision Systems in depth with Eureka
Go past this page: query the whole robotic surgery vision systems corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.